NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
02 April 2025
| Name: | ELIXINOL GLOBAL LIMITED (EXL) (This company subsequently changed its name to ELIXINOL WELLNESS LIMITED. You should refer to that name for Status.) | ||||||
| ISIN: | AU000000EXL4 | ||||||
| Date of Listing: | 08 January 2018 | ||||||
| Subsequent Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to ELIXINOL WELLNESS LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
ACN: 621 479 794ABN: 34 621 479 794
Registration Date: 04 September 2017
Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now ELIXINOL WELLNESS LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| ELIXINOL WELLNESS LIMITED | 19/05/2021 | |
| ELIXINOL GLOBAL LIMITED | 19/05/2021 |
Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Elixinol Wellness Limited | 19/05/2021 |
The suspension of trading in the securities of Elixinol Global Limited will be lifted immediately following the release by EXL of an announcement regarding a binding agreement to acquire CannaCare Health GmbH. | 15/03/2021 |
Elixinol signs binding agreement to acquire CannaCare Health GmbH, owner of CANOBO, one of Germany's leading CBD brands with #1 share in Germany's drugstore channel. Expected to fast-track revenue and path to profitability growth for the Group. Proposed acquisition is highly synergistic, enabling consolidation of European supply chain, ability to leverage existing cost base and capabilities and expand the combined product portfolio into new geographies and categories. The combination of CannaCare with Elixinol's UK business is expected to create a pan-European business of scale, well positioned to capitalise on a burgeoning European CBD market. Follows recent down-scheduling of CBD in Europe and aligns with Elixinol's vision of becoming "a global, hemp derived health and wellness consumer products business". Elixinol Board to be strengthened with the addition of Frank Otto, CannaCare's major shareholder and media entrepreneur. Completion is subject to satisfaction of customary conditions precedent, approvals from the ASX and approval by Elixinol's shareholders, expected to be sought at the upcoming Annual General Meeting, anticipated to be held in mid-May 2021. Investor briefing to be held on Tuesday 16 March 2021 at 11:00am, AEDT. | 15/03/2021 |
The securities of Elixinol Global Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of EXL, pending the release of an announcement regarding a potential transaction. | 08/03/2021 |
listed entity carried for record purposes only | 08/01/2018 |
name changed to Elixinol Wellness Limited | 19/05/2021 |
The suspension of trading in the securities of Elixinol Global Limited will be lifted immediately following the release by EXL of an announcement regarding a binding agreement to acquire CannaCare Health GmbH. | 15/03/2021 |
Elixinol signs binding agreement to acquire CannaCare Health GmbH, owner of CANOBO, one of Germany's leading CBD brands with #1 share in Germany's drugstore channel. Expected to fast-track revenue and path to profitability growth for the Group. Proposed acquisition is highly synergistic, enabling consolidation of European supply chain, ability to leverage existing cost base and capabilities and expand the combined product portfolio into new geographies and categories. The combination of CannaCare with Elixinol's UK business is expected to create a pan-European business of scale, well positioned to capitalise on a burgeoning European CBD market. Follows recent down-scheduling of CBD in Europe and aligns with Elixinol's vision of becoming "a global, hemp derived health and wellness consumer products business". Elixinol Board to be strengthened with the addition of Frank Otto, CannaCare's major shareholder and media entrepreneur. Completion is subject to satisfaction of customary conditions precedent, approvals from the ASX and approval by Elixinol's shareholders, expected to be sought at the upcoming Annual General Meeting, anticipated to be held in mid-May 2021. Investor briefing to be held on Tuesday 16 March 2021 at 11:00am, AEDT. | 15/03/2021 |
The securities of Elixinol Global Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of EXL, pending the release of an announcement regarding a potential transaction. | 08/03/2021 |
listed entity carried for record purposes only | 08/01/2018 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 21/09/2023 | Pauline Gately | -3,349,581 | $0.007 | $23,447 |
| 18/10/2021 | Helen Wiseman | 112,000 | $0.091 | $10,192 |
| 29/09/2020 | Helen Wiseman | 79,896 | $0.155 | $12,384 |
| 28/09/2020 | Oliver Horn | 90,000 | $0.150 | $13,500 |
| 16/09/2020 | Paul Benhaim | -8,100,000 | $0.148 | $1,200,000 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| David Fenlon | Chairman | 28/03/2022 |
| Ron Dufficy | Managing Director, CEO | 08/01/2018 |
| Josephine Lorenz | CFO | 08/04/2022 |
| Pauline Gately | Non Exec Director, Company Secretary | 17/08/2023 |
| Tai Minh Phan | Company Secretary | 01/07/2024 |
| Melanie Leydin | Company Secretary | 01/07/2024 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Sarah Prince | Company Secretary | 01/07/2024 | |
| Helen Wiseman | Chairman | 21/04/2020 | 30/09/2023 |
| Oliver Horn | Non Exec Director | 21/04/2020 | 06/04/2023 |
| Paul Benhaim | Non Exec Director | 06/09/2017 | 06/04/2023 |
| Stratos Karousos | Executive Director, CEO | 04/09/2017 | 21/04/2020 |
| Andrew Duff | Non Exec Chairman, Independent Director | 27/11/2017 | 06/04/2020 |
| Greg Ellery | Non Exec Director | 12/04/2019 | 06/04/2020 |
| Linda McLeod | Executive | 04/09/2017 | 20/07/2019 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
